The Importance of Standardization on Analyzing Circulating RNA
- PMID: 28039578
- PMCID: PMC5426982
- DOI: 10.1007/s40291-016-0251-y
The Importance of Standardization on Analyzing Circulating RNA
Abstract
Circulating RNAs, especially microRNAs (miRNAs), have recently emerged as non-invasive disease biomarkers. Despite enthusiasm and numerous reports on disease-associated circulating miRNAs, currently there is no circulating miRNA-based diagnostic in use. In addition, there are many contradictory reports on the concentration changes of specific miRNA in circulation. Here we review the impact of various technical and non-technical factors related to circulating miRNA measurement and elucidate the importance of having a general guideline for sample preparation and concentration measurement in studying circulating RNA.
Conflict of interest statement
The authors (Kai Wang, Inyoul Lee, David Baxter, Min Young Lee, and Kelsey Scherler) declare that they have no competing interests.
References
-
- Mandel P, Metais P. Comptes rendus des seances de la Societe de biologie et de ses filiales. 1948;142(3–4):241–3. Not Available. - PubMed
-
- Kopreski MS, et al. Detection of tumor messenger RNA in the serum of patients with malignant melanoma. Clinical cancer research: an official journal of the American Association for Cancer Research. 1999;5(8):1961–5. - PubMed
-
- Barzon L, et al. Evaluation of circulating thyroid-specific transcripts as markers of thyroid cancer relapse. International journal of cancer. 2004;110(6):914–20. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
